SMI Equal Weight
401,07
PKT
+0,02
PKT
±0,00
%
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.12 | UBS overweight | J.P. Morgan Cazenove | |
| 19.07.12 | UBS hold | Deutsche Bank AG | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis buy | Sarasin Research | |
| 19.07.12 | UBS underperform | Exane-BNP Paribas SA | |
| 19.07.12 | Swisscom neutral | Nomura | |
| 19.07.12 | ABB (Asea Brown Boveri) hold | ING | |
| 19.07.12 | Logitech hold | Vontobel Research | |
| 19.07.12 | UBS equal-weight | Morgan Stanley | |
| 19.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 19.07.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.07.12 | UBS hold | Vontobel Research | |
| 19.07.12 | UBS halten | Independent Research GmbH | |
| 18.07.12 | UBS buy | Citigroup Corp. | |
| 18.07.12 | UBS buy | Citigroup Corp. | |
| 18.07.12 | UBS neutral | Sarasin Research | |
| 18.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 18.07.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 17.07.12 | Novartis buy | Deutsche Bank AG | |
| 17.07.12 | Kühne + Nagel International neutral | UBS AG | |
| 17.07.12 | Kühne + Nagel International buy | Nomura | |
| 17.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 17.07.12 | Novartis buy | UBS AG | |
| 17.07.12 | Nestlé hold | ING | |
| 17.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 17.07.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 17.07.12 | Zurich Insurance buy | Sarasin Research | |
| 16.07.12 | Givaudan reduce | Nomura | |
| 16.07.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 16.07.12 | Swisscom buy | Deutsche Bank AG | |
| 16.07.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 16.07.12 | UBS underperform | Exane-BNP Paribas SA | |
| 16.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 16.07.12 | UBS outperform | Keefe, Bruyette & Woods, Inc. | |
| 13.07.12 | Swiss Re underperform | Banc of America Securities-Merrill Lynch | |
| 13.07.12 | Novartis buy | Nomura |